Updates are available Correction dated 2025-01-06
Click to view Correction: https://doi.org/10.1186/s42238-024-00254-8
-
Authors
Zolotov, Yuval https://orcid.org/0000-0002-5391-7379
Lomba, Jacinta
Ghiroli, Megan
Masyukova, Mariya
Arnsten, Julia H.
Starrels, Joanna L.
Ross, Jonathan
Cunningham, Chinazo O.
Slawek, Deepika E.
-
Funding
Funding for this research was provided by:
National Institute on Drug Abuse (R01DA044171, K24DA036955, K24DA046309, K23DA053997)
National Institute of Mental Health (K23MH114752)
National Institute of Allergy and Infectious Diseases (P30AI124414)
- License Information
-
More Information
Article History
Received: 2 September 2022
Accepted: 17 March 2023
First Online: 29 March 2023
Change Date: 29 December 2024
Change Type: Update
Change Details: The original online version of this article was revised: In the competing interest section, the following information has been added: Author JA is an editor for Journal of Cannabis Research. Author JA was not involved in the journal’s review of, or decisions related to this manuscript.
Change Date: 6 January 2025
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1186/s42238-024-00254-8
Declarations
:
: The Medical Marijuana and Opioids (MEMO) Study (IRB# 2017–7857) and this qualitative component of it (IRB# 2019–10351) were approved by the Albert Einstein College of Medicine Institutional Review Board. All participants provided informed consent.
: Not applicable.
: The authors declare that they have no competing interests. Author JA is an editor for Journal of Cannabis Research. Author JA was not involved in the journal’s review of, or decisions related to this manuscript.
